Patents by Inventor Zoltán PRÁGAI

Zoltán PRÁGAI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220010291
    Abstract: The present invention is related to an improved process for production of vitamin B2 using a genetically engineered host cell comprising a heterologous enzyme with pyridoxal phosphatase activity. Using said modified host cell, the yield of riboflavin production could be increased by at least about 5%.
    Type: Application
    Filed: November 11, 2019
    Publication date: January 13, 2022
    Inventors: Christopher Mark FARRELL, Sébastien Eric POTOT, Zoltán PRÁGAI, Michael Patrick ANAYA
  • Patent number: 8551732
    Abstract: The present invention relates to newly identified mRNA stabilizing elements useful for the production of a target fermentation product, such as e.g. vitamins or enzymes, in particular riboflavin (vitamin B2), biotin, pantothenic acid (vitamin B5), folic acid, thiamin, pyridoxine (vitamin B6), vitamin B12, xylanase, amylase, protease, glucanase, amylomaltase or maltogenic amylase.
    Type: Grant
    Filed: June 9, 2008
    Date of Patent: October 8, 2013
    Assignee: DSM IP Assets B.V.
    Inventors: Martin Lehmann, Zoltan Pragai, Michéle Schaber
  • Publication number: 20130216653
    Abstract: The present invention relates to the display of bioactive molecules at the surface of spores for both in vitro and in vivo applications. Three small open reading frames (ORFs) have been identified which are very useful for display of bioactive molecules at the spore surface. The encoded small proteins have a molecular weight of less than 12 kDa, which corresponds to about less than 100 amino acids.
    Type: Application
    Filed: June 28, 2011
    Publication date: August 22, 2013
    Applicant: DSM IP ASSETS B.V.
    Inventors: John B. Perkins, Zoltan Pragai, Ghislain Schyns
  • Publication number: 20100173356
    Abstract: The present invention relates to newly identified mRNA stabilizing elements useful for the production of a target fermentation product, such as e.g. vitamins or enzymes, in particular riboflavin (vitamin B2), biotin, pantothenic acid (vitamin B5), folic acid, thiamin, pyridoxine (vitamin B6), vitamin B12, xylanase, amylase, protease, glucanase, amylomaltase or maltogenic amylase.
    Type: Application
    Filed: June 9, 2008
    Publication date: July 8, 2010
    Inventors: Martin Lehmann, Zoltan Pragai, Michèle Schaber